Shuttle Pharmaceuticals Holdings, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by HRT FINANCIAL LP, was filed 13 Jul 2026.
Shuttle Pharmaceuticals Holdings, Inc.: what insiders have been doing
Every trade that managers of Shuttle Pharmaceuticals Holdings, Inc. disclose to SEC (Form 4) is tracked on this page. The company sits in the Health Care sector. From 22 October 2025 to 22 October 2026, the disclosure feed for Shuttle Pharmaceuticals Holdings, Inc. logged 8 filings by 1 insider.
On the market, 1 insider bought (3 purchases totalling €51k) while 1 insider sold (5 sales totalling €443k). On balance, insiders were net sellers of €392k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. At €323k, the sale published on 15 July 2026 by HRT Financial LP is the largest of the period (0.023% of market cap). The buyers include 1 major shareholder.
With 8 filings in twelve months, the company is quieter than the median of 24 filings across the 3,171 companies we follow on the same exchange. The full history, which starts in 2022, counts 3 purchases against 17 sales. For the fiscal year to 31 December 2025, the annual 10-K puts net income at -11.7 m USD.
The clock since the last published purchase (13 July 2026) now reads 119 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +31.0%Entry US$41.46 · Close at T+90 US$54.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,033 shares@ US$4.670.0003% mcap0.9% of flowCommon StockSEC:0001475597-26-000159:0
- 82,116 shares@ US$4.480.023% mcap65.4% of flowCommon StockSEC:0001475597-26-000159:1
- 731 shares@ US$3.110.0001% mcap0.4% of flowCommon StockSEC:0001475597-26-000154:1Canonical exit: 8 Oct 2026 (T+90)
- 8,266 shares@ US$3.380.0017% mcap5.0% of flowCommon StockSEC:0001475597-26-000154:0Canonical exit: 7 Oct 2026 (T+90)
- 10,580 shares@ US$3.330.0022% mcap6.2% of flowCommon StockSEC:0001475597-26-000144:0
- 18,531 shares@ US$3.520.0040% mcap11.6% of flowCommon StockSEC:0001475597-26-000144:1
- 7,851 shares@ US$3.540.0017% mcap4.9% of flowCommon StockSEC:0001475597-26-000138:0Canonical exit: 30 Sept 2026 (T+90)
- 9,022 shares@ US$3.510.0019% mcap5.6% of flowCommon StockSEC:0001475597-26-000138:1
- 598 shares@ US$11.2892.7% of flowCLASS A COMMON STOCKSEC:0001493152-24-040614:0
- 1,626 shares@ US$1.605100.0% of flowCOMMON STOCKSEC:0001493152-24-009980:0
- 100,000 shares0COMMON STOCKSEC:0001493152-24-009451:0
- 2,921 shares@ US$0.463245.5% of flowCommon StockSEC:0001493152-24-000125:0
- 4,157 shares@ US$0.463221.3% of flowCommon StockSEC:0001493152-23-045648:0
- 2,100,000 shares0COMMON STOCKSEC:0001493152-23-029472:1
- 2,100,000 shares0COMMON STOCKSEC:0001493152-23-029472:0
- 995 shares@ US$1.605100.0% of flowCOMMON STOCKSEC:0001493152-23-000941:0
- 995 shares@ US$1.605100.0% of flowCOMMON STOCKSEC:0001493152-23-000319:0
- 995 shares@ US$1.60554.5% of flowCOMMON STOCKSEC:0001493152-23-000318:0
- 1,414 shares@ US$1.605100.0% of flowCOMMON STOCKSEC:0001493152-23-000014:0
- 4,366 shares@ US$1.60578.7% of flowCLASS A COMMON STOCKSEC:0001493152-23-000012:0
- 8,372 shares@ US$1.605100.0% of flowCOMMON STOCKSEC:0001493152-23-000026:0
- 328 shares@ US$1.6057.3% of flowCLASS A COMMON STOCKSEC:0001493152-23-000013:0
- 2,243 shares@ US$1.605100.0% of flowCOMMON STOCKSEC:0001493152-22-037141:0
- 3,820 shares@ US$1.605100.0% of flowCOMMON STOCKSEC:0001493152-22-037210:0
24 of 24 declarations
About Shuttle Pharmaceuticals Holdings, Inc.
Shuttle Pharmaceuticals Holdings, Inc. is a company focused on developing innovative pharmaceutical treatments. It specializes in researching and commercializing therapeutic solutions for serious diseases.
